Acetyl-Group Metabolic Enzyme Network and In Vitro Enzymology Analysis

Acetyl-group metabolism lies at the intersection of central carbon metabolism, lipid synthesis, post-translational protein modification, and epigenetic regulation. Interconversion among acetyl-CoA, acetate, citrate, and multiple acyl intermediates not only determines the direction of carbon-flux partitioning, but also directly influences protein acetylation states, metabolic-enzyme activity, and cellular functional output. Accordingly, research centered on key enzymatic nodes involved in acetyl-group generation, transport, transfer, and removal is an important component of pathway analysis and in vitro enzymology.

 

Keywords: acetyl-group metabolism; acetyl-CoA; acetyltransferases; deacetylases; pathway analysis; in vitro enzymology; central carbon metabolism; epigenetic regulation

 

1. Framework of Acetyl-Group Metabolism

1.1 Metabolic positioning and analytical hierarchy

(1) The dual attributes of the acetyl group

On the one hand, the acetyl group enters the tricarboxylic acid cycle, fatty acid synthesis, cholesterol synthesis, and ketone-body metabolism. On the other hand, it participates in chromatin regulation, control of protein stability, and remodeling of enzyme activity through lysine acetylation, N-terminal acetylation, and related processes. Thus, acetyl-group metabolism is not merely a process of material conversion, but a key layer coupling metabolic input with functional output.

(2) Integrated analysis of the donor layer and the modification layer

If only acetyl-CoA abundance is measured without analyzing acetyltransferase and deacetylase activity, differences in acetylation phenotypes are difficult to interpret. Conversely, if only acetylation levels are measured without tracing donor origin and compartmental distribution, it is difficult to establish a causal relationship between metabolic supply and modification changes. Therefore, studies of acetyl-group metabolism should adopt an analytical framework linking source, distribution, transfer, removal, and functional consequences.

 

1.2 Compartment specificity and carbon-flux coupling

(1) Differences in acetyl-group supply across subcellular compartments

Mitochondrial acetyl-CoA is mainly derived from pyruvate oxidation, fatty acid beta-oxidation, and degradation of certain amino acids, whereas cytosolic and nuclear acetyl-CoA depends more heavily on citrate cleavage and acetate reactivation. Therefore, different acetylation events within the same cell show clear compartment dependence.

(2) Effects of intercompartmental transport on acetyl-group accessibility

The citrate shuttle, acetate reutilization, and ketone-body metabolism can all alter acetyl-group availability in different compartments. Therefore, research on acetyl-group metabolic enzymes should not remain limited to measurement of a single enzyme activity, but must also be interpreted in conjunction with intercompartmental transport and metabolic coupling.

 

2. Nodes of Acetyl-Group Donor Generation

2.1 Glucose-derived entry points into the acetyl pool

(1) Pyruvate dehydrogenase complex

After glucose is converted to pyruvate through glycolysis, pyruvate must be converted to acetyl-CoA by the pyruvate dehydrogenase complex before it can enter the tricarboxylic acid cycle and multiple acetyl-dependent pathways. Accordingly, the PDH complex is a key entry node through which glucose-derived carbon flux is introduced into the acetyl pool.

(2) Activity regulation and flux limitation

PDH is regulated by phosphorylation, dephosphorylation, substrate supply, and the NADH/NAD+ state. Changes in its activity can markedly affect the capacity for mitochondrial acetyl-CoA generation. Therefore, in pathway analysis, PDH is not only a metabolic node, but also an important threshold node for entry of glucose-derived carbon flux into the acetyl-group metabolic network.

 

2.2 Formation of cytosolic and nuclear acetyl-group donors

(1) Carbon-output conversion mediated by ATP-citrate lyase

ACLY catalyzes the cleavage of citrate to produce acetyl-CoA and oxaloacetate, and is an important donor source for cytosolic lipid synthesis and nuclear acetylation reactions. Its function is not limited to replenishing cytosolic acetyl-CoA, but extends to converting mitochondria-derived carbon flux into acetyl-group input available for epigenetic regulation.

(2) Acetate reactivation mediated by the acetyl-CoA synthetase family

ACSS2 mainly catalyzes conversion of acetate into acetyl-CoA in the cytosol and nucleus, whereas ACSS1 is more strongly associated with mitochondrial localization. This pathway is particularly important under conditions of nutrient limitation, hypoxia, acetate enrichment, and metabolic reprogramming, and serves as a key node for non-glucose-derived acetyl-group supply.

 

2.3 Alternative sources of acetyl groups

(1) Fatty acid beta-oxidation pathway

After long-chain fatty acids enter mitochondria, they continuously generate acetyl-CoA through beta-oxidation. Therefore, under high-fat conditions, starvation, and certain tumor-metabolic contexts, lipid-derived acetyl groups may constitute an important source of supply.

(2) Ketone-body utilization pathway

Acetoacetate and beta-hydroxybutyrate can be converted back to acetyl-CoA through the relevant enzyme systems, thereby supplementing both energy metabolism and acetyl-group supply. Accordingly, ketone-body utilization should be incorporated into the source-classification framework in acetyl-group pathway analysis.

Table 1. Key enzymes related to acetyl-group donor generation and their functional positioning

 

Enzyme / Enzyme Complex	Main Substrate	Main Product	Functional Positioning	Main Research Significance
Pyruvate dehydrogenase complex (PDH)	Pyruvate	Acetyl-CoA	Entry point for glucose-derived acetyl groups	Coupling of glycolysis to the TCA cycle and acetylation pathways
ATP-citrate lyase (ACLY)	Citrate	Acetyl-CoA	Cytosolic / nuclear acetyl-group supply	Coupling of lipid synthesis and epigenetic acetylation
Acetyl-CoA synthetase 1/2 (ACSS1/2)	Acetate	Acetyl-CoA	Acetate reactivation	Supply of non-glucose-derived acetyl groups
Carnitine palmitoyltransferase system (CPT)	Long-chain fatty acyl groups	Entry into the beta-oxidation pathway	Carbon-entry point for fatty acids	Formation of lipid-derived acetyl groups
Ketone-body-metabolism-related enzymes	Ketone bodies	Acetyl-CoA	Alternative source of acetyl groups	Studies of starvation and metabolic reprogramming
Phosphotransacetylase (PTA)	Acetyl-CoA, inorganic phosphate	Acetyl phosphate, CoA	Interconversion node between acetyl-CoA and acetyl phosphate	Acetate metabolism, acetyl-phosphate bypass, and microbial acetyl-flux analysis

 

3. Acetyl-Group Transfer Nodes

3.1 Protein acetyltransferase systems

(1) Lysine acetyltransferases

The KAT family uses acetyl-CoA as a donor to transfer acetyl groups to lysine residues on histones and non-histone proteins. This process can alter chromatin accessibility, transcription-complex assembly, and the functional state of metabolic enzymes, and therefore serves as a central bridge through which acetyl groups move from the metabolic pool into the functional layer.

(2) Substrate selectivity and site specificity

Different KAT family members exhibit distinct preferences for substrate proteins, peptide sequences, structural environments, and subcellular localization. Therefore, even when acetyl-CoA supply is sufficient, output from different acetyltransferase systems may still differ substantially.

 

3.2 Noncanonical acetylation outputs

(1) N-terminal acetylation

In addition to lysine acetylation, N-terminal acetylation is also an important protein-modification mode, with sustained effects on protein stability, localization, and molecular interactions. Therefore, acetyl-group transfer is not limited to histones and classical non-histone substrates.

(2) Small-molecule acetylation branches

Certain small-molecule metabolites can also undergo acetylation, thereby altering their activity, solubility, and metabolic fate. Thus, in pathway analysis, acetyl-group consumption should not be restricted solely to the protein-modification level.

 

4. Deacetylation Nodes

4.1 HDAC family

(1) Zn2+-dependent deacetylation systems

The HDAC family removes acetyl groups from lysine residues on proteins through hydrolytic reactions and is a major determinant of acetylation homeostasis in nuclear and cytosolic proteins. Changes in their expression and activity can directly affect the duration and magnitude of acetylation signaling.

(2) The reverse interpretive dimension of acetylation phenotypes

In studies of acetyl-group metabolism, a decrease in acetylation level does not necessarily arise from insufficient donor supply; it may also result from increased HDAC activity. Therefore, deacetylation nodes must be analyzed in parallel with donor-generation nodes.

 

4.2 Sirtuin family

(1) NAD+-dependent deacetylation links energy status to acetylation control

The Sirtuin family requires NAD+ to drive deacetylation reactions, and its activity is therefore tightly linked to redox state, mitochondrial function, and cellular energy balance. This feature makes Sirtuins an important node connecting metabolic status with acetylation output.

(2) Compartmental distribution and functional stratification

Distinct Sirtuin family members localized in the nucleus, cytosol, and mitochondria participate respectively in chromatin regulation, signaling-protein modification, and deacetylation of mitochondrial metabolic enzymes. Accordingly, research design should select the relevant deacetylation node on the basis of compartmental context.

 

5. Strategies for Pathway Analysis

5.1 Determination of acetyl-group origin

(1) Distinguishing the relative contribution of multiple sources

An increase in total acetyl-CoA does not directly identify its origin. Substrate deprivation, stable-isotope tracing, and key-enzyme inhibition strategies are required to distinguish the relative contributions of glucose, fatty acids, acetate, or ketone bodies to the acetyl pool.

(2) Nonequivalence between source and output layer

Mitochondria-derived acetyl groups are more strongly associated with energy metabolism and local protein acetylation, whereas cytosolic/nuclear acetyl groups more readily affect lipid synthesis and histone acetylation. Therefore, source determination must be extended further to analysis of downstream destination.

 

5.2 Analysis of acetyl-group fate

(1) Synthetic-metabolism-prioritized consumption pathways

Fatty acid, cholesterol, and isoprenoid synthesis all consume acetyl groups. Therefore, an increase in acetyl-CoA does not necessarily correspond first to enhanced acetylation; it may instead be preferentially consumed by anabolic pathways.

(2) Protein-modification output pathways

Histones, transcription factors, and multiple metabolic enzymes can all accept acetyl-group modification. Therefore, pathway studies must simultaneously examine donor levels, acetyltransferase activity, and target-protein acetylation states in order to establish a complete flux-to-modification relationship.

Table 2. Major analytical dimensions in acetyl-group metabolic pathway analysis

 

Analytical Dimension	Main Nodes	Main Readouts	Questions Addressed
Source determination	PDH, ACLY, ACSS, CPT, ketone-body-metabolism enzymes, PTA	Isotope tracing, acetyl-CoA abundance, acetyl-phosphate changes	Where do the acetyl groups come from
Compartmental supply	Mitochondria, cytosol, nucleus	Compartment-specific metabolites, compartment-specific enzyme activity	Where are acetyl groups distributed
Modification writing	KAT, NAT, etc.	Protein acetylation level, substrate specificity	How do acetyl groups enter the functional layer
Modification erasure	HDAC, Sirtuin	Deacetylation rate, NAD+ dependence	How is acetylation reversed
Functional output	Metabolic enzymes, histones, transcription factors	Pathway flux, epigenetic state, phenotype	What consequences do acetyl-group changes produce

 

6. Design of In Vitro Enzymology Studies

6.1 Studies of donor-forming enzymes

(1) Distinguishing upstream substrates from direct donors

For targets such as PDH, ACLY, ACSS2, and PTA, the principal focus is generation and interconversion of acetyl-group donors or related high-energy intermediates, rather than acetyl-group transfer itself. Therefore, in vitro studies should clearly distinguish whether the analysis concerns donor-formation efficiency or downstream acetylation output.

(2) Determinative role of cofactor systems

CoA, ATP, NAD+, Mg2+, and inorganic phosphate all affect the reaction efficiency of donor-forming enzymes. If cofactor composition is ignored, system limitations can easily be misinterpreted as enzyme-specific differences.

 

6.2 Studies of acetyltransferases

(1) Synchronous standardization of donor and acceptor substrates

Studies of acetyltransferases require simultaneous control of donor concentration, acceptor-peptide structure, reaction time, and ionic environment in order to distinguish differences in substrate binding from differences in catalytic efficiency.

(2) Kinetic parameters take priority over endpoint readouts

Measurement of endpoint acetylation alone cannot distinguish between whether modification occurred and how efficient the modification process was. Therefore, in in vitro enzymology, analysis should incorporate Km, kcat, competitive inhibition, and substrate-preference parameters.

 

6.3 Studies of deacetylases

(1) Enzyme-type differences and system configuration

HDAC studies must pay attention to Zn2+-dependent conditions, whereas Sirtuin studies must focus on controlling NAD+ concentration and redox background. These two classes of deacetylases should not be interpreted under a single unified set of conditions.

(2) Substrate level and the limits of extrapolation

Rates and selectivity conclusions derived from short peptide substrates, full-length protein substrates, or chromatin-like substrates are not equivalent. Therefore, substrate level should be matched to the research question.

Table 3. Common design modules in in vitro enzymology studies related to acetyl-group metabolism

 

Research Target	Core Substrates	Key Cofactors / Donors	Main Readouts	Questions Addressed
Donor-forming enzymes such as PDH / ACLY / ACSS2 / PTA	Pyruvate, citrate, acetate, acetyl-CoA, inorganic phosphate	CoA, ATP, NAD+, etc.	Acetyl-CoA / acetyl-phosphate generation, substrate consumption	Analysis of acetyl-group origin and intermediate interconversion
Acetyltransferases such as KAT / NAT	Acetyl-CoA + protein / peptide substrates	Acetyl-CoA	Acetylation level, kinetic parameters	Target specificity and catalytic efficiency
Deacetylases such as HDAC / Sirtuin	Acetylated peptides / proteins	Zn2+ or NAD+	Deacetylation rate, product release	Acetylation reversibility and homeostatic regulation
Multi-enzyme reconstitution systems	Multiple serial substrates	Multi-enzyme and cofactor combinations	Carbon-flux partitioning and intermediate changes	Pathway coupling and rate-limiting-node analysis

 

7. Representative Research Scenarios

7.1 Tumor metabolic reprogramming

(1) Rearrangement of acetyl-group supply and epigenetic remodeling

Tumor cells often enhance ACLY, ACSS2, or fatty acid oxidation pathways to increase cytosolic and nuclear acetyl-CoA supply, thereby supporting lipid synthesis and histone acetylation.

(2) Coordinated regulation of donor formation and deacetylation

Enhanced acetyl-group input and altered HDAC/Sirtuin activity often coexist. The former determines modification-writing capacity, whereas the latter determines the strength of modification erasure. Accordingly, both should be analyzed together.

 

7.2 Immunometabolism research

(1) Inflammatory transcriptional programs and acetyl-group supply

During immune-cell activation, changes in acetyl-CoA levels can directly affect the histone-acetylation state of inflammation-related genes, thereby altering the amplitude of the transcriptional response.

(2) Deacetylation networks in effector differentiation

Sirtuin-mediated deacetylation is closely linked to oxidative metabolism, oxidative stress, and immune-cell differentiation states, and therefore holds important significance in immunometabolism research.

 

7.3 Mitochondrial function research

(1) Joint control by local donor supply and local deacetylation

The acetylation state of mitochondrial metabolic enzymes can affect oxidative phosphorylation, fatty acid oxidation, and stress defense. Accordingly, both donor origin and local deacetylation capacity must be analyzed together.

(2) Functional decline caused by disrupted acetylation homeostasis

Restricted donor generation, decreased NAD+, or insufficient Sirtuin activity may all lead to abnormal mitochondrial acetylation profiles and consequent functional impairment.

 

8. Research Products Relevant to Studies of Acetyl-Group Metabolism

8.1 Basic reaction and regulatory reagents

Table 4. Basic reaction and regulatory reagents in acetyl-group metabolic pathway analysis

 

Name	CAS No.	Experimental Stage	Key Use	Use Notes
Glacial acetic acid	64-19-7	Studies of acetate sources	Used as an acetate substrate source for ACSS-related reactivation and acetate-supplementation model construction	Suitable for studies of acetate-dependent acetyl-group generation
Sodium acetate	127-09-3	Studies of acetate sources	Used as a milder acetate-supplying form for acetate reactivation and feeding experiments	Suitable for acetate supplementation in cellular and in vitro systems
Pyruvic acid	127-17-3	Studies of glucose-derived acetyl groups	Used for reconstruction of the PDH pathway and analysis of glucose-derived carbon entry into acetyl-CoA	Suitable for in vitro enzymology and substrate-competition studies
Sodium pyruvate	113-24-6	Studies of glucose-derived acetyl groups	Used as a stable substrate form in PDH-related in vitro systems and cellular supplementation studies	Suitable for analysis of glucose-derived acetyl-group formation
Citric acid	77-92-9	Studies of cytosolic acetyl-group generation	Used as an ACLY substrate for analysis of citrate cleavage and cytosolic/nuclear acetyl-group supply	Suitable for construction of ACLY reaction systems
Trisodium citrate dihydrate	6132-04-3	Studies of cytosolic acetyl-group generation	Used as a more strongly buffered citrate source in cellular and in vitro supplementation systems	Suitable for simulation of cytosolic acetyl-group supply
ATP disodium salt	987-65-5	Studies of donor-forming enzymes	Provides the energy substrate for ATP-dependent reactions such as ACSS	Commonly used together with Mg2+
NAD+	53-84-9	Studies of donor formation and deacetylation	Used in PDH and Sirtuin systems to connect redox state with deacetylation reactions	Suitable for metabolism-acetylation coupling studies
NADH disodium salt	606-68-8	Studies of donor formation	Used to analyze redox feedback and reaction balance in reactions such as PDH	Suitable for studies of regulation by reduced states
Thiamine pyrophosphate chloride	154-87-0	Studies of the PDH system	Used as an important coenzyme in PDH-related reactions for full reconstruction of the glucose-derived acetyl-entry system	Suitable for in vitro PDH activity assays
Magnesium chloride	7786-30-3	Enzymology-system optimization	Provides ionic support for ATP-dependent reactions and multiple enzymatic systems	Commonly used in optimization of ACSS and related systems
Sodium dihydrogen phosphate	7558-80-7	Studies of PTA and buffer systems	Provides an inorganic phosphate source and constructs phosphate buffer systems	Suitable for PTA- and acetyl-phosphate-related studies
Disodium hydrogen phosphate	7558-79-4	Studies of PTA and buffer systems	Adjusts phosphate-buffer conditions and participates in inorganic phosphate supply	Suitable for screening in vitro PTA reaction conditions
Tris	77-86-1	Buffer-system construction	Provides a neutral to mildly alkaline enzymatic reaction environment	Suitable for most in vitro enzymatic reaction systems
HEPES	7365-45-9	Buffer-system construction	Used in in vitro enzymology under mild buffering conditions	Suitable for systems requiring relatively high protein stability
Nicotinamide	98-92-0	Deacetylation-regulation studies	Used in Sirtuin-related intervention and deacetylation-mechanism analysis	Suitable for studies of NAD+-dependent deacetylation
Sodium butyrate	156-54-7	Acetylation-regulation studies	Commonly used as an experimental intervention to increase intracellular acetylation levels	Suitable for HDAC-related functional studies
Trichostatin A	58880-19-6	Studies of deacetylation inhibition	Used as a classical HDAC inhibitor to elevate acetylation levels and analyze the contribution of deacetylation	Suitable for HDAC functional validation
Vorinostat	149647-78-9	Studies of deacetylation inhibition	Used for HDAC inhibition and acetylation-enhancement experiments	Suitable for studies of epigenetic-acetylation intervention
Resveratrol	501-36-0	Deacetylation-regulation studies	Commonly used in Sirtuin-related regulatory studies	Suitable for analysis of coupling between metabolic state and deacetylation
L-Carnitine	541-15-1	Studies of lipid-derived acetyl groups	Used in research related to fatty-acid entry into mitochondria and auxiliary analysis of lipid-derived acetyl-group supply	Suitable for construction of fatty-acid-oxidation models
L-Acetylcarnitine hydrochloride	5080-50-2	Studies of acetyl-group transport	Used to analyze acetyl-group transport and acetyl-group storage forms	Suitable for studies of mitochondrial-cytosolic acetyl exchange
Palmitic acid	57-10-3	Studies of lipid-derived acetyl groups	Used as a long-chain fatty-acid substrate in studies of acetyl-group generation through fatty-acid oxidation	Suitable for establishment of lipid-derived carbon-supply models
Sodium beta-hydroxybutyrate	150-83-4	Studies of ketone-body-derived acetyl groups	Used in studies of ketone-body metabolism and alternative acetyl-group sources	Suitable for starvation or metabolic-reprogramming models
Sodium dichloroacetate	2156-56-1	Studies of PDH regulation	Commonly used to promote PDH flux and analyze regulation of the glucose-derived acetyl entry point	Suitable for experiments enhancing glucose-derived carbon supply
Sodium 4-phenylbutyrate	1716-12-7	Acetylation-regulation studies	Can be used for intervention in acetylation state and analysis of cellular metabolic responses	Suitable for studies of metabolism-epigenetic coupling

 

8.2 Functional proteins and molecular tools

Table 5. Functional proteins and molecular tools in enzymology studies of acetyl-group metabolism

 

Catalog No.	Name	Grade and Purity	Experimental Stage	Key Use	Use Notes
P1515804	Pyruvate Dehydrogenase (PDH) Activity Assay Kit (DCPIP, Micro Method)	BioReagent	Study of glucose-derived acetyl entry	Used to detect changes in PDH activity and evaluate the capacity for conversion of pyruvate into acetyl-CoA	Suitable for in vitro or tissue-sample analysis under conditions of altered glucose-derived carbon supply, PDH inhibition, or PDH activation
A1515845	ATP Citrate Lyase (ACL) Activity Assay Kit (UV Micro Method)	BioReagent	Study of cytosolic acetyl-group supply	Used to detect ACLY activity and analyze the capacity of citrate cleavage to supply cytosolic/nuclear acetyl groups	Suitable for study designs with limited sample amounts or requiring high-throughput comparison
A1515964	ATP Citrate Lyase (ACL) Activity Assay Kit (UV Colorimetric Method)	BioReagent	Study of cytosolic acetyl-group supply	Used for quantitative evaluation of ACLY catalytic efficiency and its impact on acetyl-donor formation	Suitable for routine enzyme-activity measurement and comparison among treatment groups
B288525	BMS 303141	≥98%	ACLY functional-intervention studies	Used to reduce cytosolic/nuclear acetyl-CoA supply by inhibiting ACLY and to analyze the dependence of lipid synthesis and acetylation writing on ACLY	Suitable for combined use with acetylation readouts, lipid-synthesis indices, and histone-acetylation assays
S286623	SB 204990	≥98% (HPLC)	ACLY functional-intervention studies	Used to validate the role of ACLY in acetyl-group source partitioning and as a pathway-intervention tool	Suitable for combined use with acetate supplementation, ACSS2 intervention, or isotope-tracing strategies
A1477391	ACSS2 Human Pre-designed siRNA Set A	—	Study of acetate reactivation	Used to knock down ACSS2 and validate the contribution of acetate replenishment to conversion into acetyl-CoA and the resulting acetylation phenotype	Suitable for cell-level causal validation and studies of metabolic reprogramming
A1423677	ACSS2-IN-1	—	Acetate-reactivation intervention studies	Used to inhibit ACSS2 activity and analyze the functional contribution of acetate-derived acetyl-group input	Suitable for combined use with acetate-supplementation models and nuclear-acetylation readouts
Ab325831	Recombinant ACSS2 Antibody	Knockdown-validated	ACSS2 expression validation	Used to detect changes in ACSS2 expression and validate siRNA- or pharmacology-based interventions	Suitable for Western blot, immunoblotting, or node-expression analysis
P1431341	Phosphate acetyltransferase	—	Study of the acetyl-phosphate bypass	Used to reconstruct the acetyl-CoA-acetyl-phosphate interconversion system and analyze acetate-metabolism branch pathways and acetyl flux	More suitable for microbial systems or in vitro reconstitution than for classical mammalian acetylation models
Ab111752	Recombinant KAT2A/GCN5 Antibody	Recombinant, ExactAb™, validated, see COA	Study of acetyl-transfer nodes	Used to detect KAT2A/GCN5 expression and analyze changes in classical lysine-acetyltransferase systems	Suitable for histone-acetylation-writing studies and transcription-regulation-related analysis
Ab111758	Recombinant KAT2B/PCAF Antibody	Recombinant, ExactAb™, validated, knockdown-validated, see COA	Study of acetyl-transfer nodes	Used to analyze changes in PCAF-mediated acetylation writing and its relationship to metabolic-donor changes	Suitable for acetyltransferase-expression validation and post-knockdown effect analysis
Ab111791	Recombinant KAT8/MYST1/MOF Antibody	ExactAb™, Validated, recombinant, 2.0 mg/mL	Study of acetyl-transfer nodes	Used to detect the KAT8/MOF acetyltransferase system and extend the scope of nuclear-acetylation research	Suitable for epigenetic regulation and chromatin-related acetylation studies
EJ1513539	Human K-acetyltransferase 5 (KAT5) ELISA Kit	BioReagent	Detection of acetyltransferase level	Used to detect changes in KAT5 level and evaluate the regulatory state of the acetyl-writing layer	Suitable for quantitative analysis of pathway nodes in human samples
S274730	script	≥97%	Studies of deacetylation inhibition	Used to inhibit HDAC activity, increase acetylation level, and validate the contribution of deacetylation	Suitable for establishment of acetylation-enhanced control groups
P127910	Pracinostat (SB939)	Moligand™, ≥98%	Deacetylation-intervention studies	Used for broad-spectrum HDAC inhibition to analyze the impact of deacetylation networks on acetylation homeostasis	Suitable for epigenetic-regulation and tumor-metabolism studies
R129686	RGFP966	≥98%	HDAC isoform-function studies	Used for selective inhibition of HDAC3 and analysis of the effects of specific deacetylation nodes on metabolism and transcription	Suitable for studies of the specific role of HDAC3 in acetylation homeostasis
R125265	Romidepsin (FK228, Depsipeptide)	Moligand™, ≥98%	HDAC1/2 functional-intervention studies	Used to analyze the regulatory effects of HDAC1/2 on nuclear acetylation levels and transcriptional states	Suitable for combined use with histone-acetylation readouts
EJ1514563	Human Histone Deacetylase 1 (HDAC1) ELISA Kit	BioReagent	HDAC-node level detection	Used to detect HDAC1 levels and assist in assessing changes in deacetylation pathways	Suitable for node quantification in human samples
EJ1514567	Human Histone Deacetylase 3 (HDAC3) ELISA Kit	BioReagent	HDAC-node level detection	Used to detect changes in HDAC3 level and, in combination with HDAC3 inhibitors, evaluate its functional contribution	Suitable for metabolism-epigenetic coupling studies
EJ1514573	Human Histone Deacetylase 6 (HDAC6) ELISA Kit	BioReagent	HDAC-node level detection	Used to analyze changes in HDAC6 and expand research on cytosolic protein deacetylation	Suitable for studies of the cytoskeleton, stress responses, and cytosolic protein modification
Ab107012	Anti-HDAC1 antibody	ExactAb™, Validated, Recombinant, High performance, 0.125 mg/mL	HDAC expression validation	Used to detect HDAC1 protein levels and validate intervention effects	Suitable for Western blot or immunodetection
Ab107042	Recombinant HDAC3 Antibody	Recombinant, ExactAb™, validated, knockdown-validated, see COA	HDAC expression validation	Used to detect HDAC3 expression and support node confirmation after knockdown or inhibition experiments	Suitable for functional-validation studies
Ab107079	Recombinant HDAC6 Antibody	Recombinant, ExactAb™, knockdown-validated, validated, high performance, see COA	HDAC expression validation	Used to analyze changes in HDAC6 expression and its impact on acetylation homeostasis	Suitable for studies of cytosolic protein deacetylation
rp169613	Recombinant Human HDAC1 Protein	Carrier-free, His-tagged, ≥85% (SDS-PAGE), see COA	In vitro deacetylase enzymology studies	Used to establish in vitro HDAC1 reaction systems and carry out inhibitor screening and enzymatic-parameter analysis	Suitable for deacetylation-substrate reactions and inhibitor evaluation
rp184896	Recombinant Human HDAC3 Protein	Carrier-free, GST-tagged, His-tagged, ≥75% (SDS-PAGE), see COA	In vitro deacetylase enzymology studies	Used to reconstruct in vitro HDAC3 systems and analyze isoform-specific inhibitory effects	Suitable for validation in combination with tools such as RGFP966
C274655	Cambinol	≥98%	Sirtuin-intervention studies	Used to inhibit SIRT1/2 and analyze the contribution of NAD+-dependent deacetylation to acetylation homeostasis	Suitable for studies of coupling between energy state and deacetylation
rp184934	Recombinant Human Sirtuin 1/SIRT1 Protein	Carrier-free, His-tagged, ≥65% (SDS-PAGE), see COA	In vitro Sirtuin enzymology studies	Used to establish in vitro SIRT1 deacetylation reaction systems and analyze NAD+-dependent catalytic characteristics	Interpretation should consider the effects of NAD+ concentration and substrate type
Ab127656	Recombinant SIRT1 Antibody	Recombinant, ExactAb™, validated, see COA	SIRT1 expression validation	Used to detect SIRT1 protein levels and support analysis of the relationship between metabolic state and deacetylation	Suitable for node-expression analysis and post-intervention validation
S129890	SRT1720 HCl	≥98%	SIRT1 functional-activation studies	Used to enhance SIRT1-related deacetylation pathways and analyze regulatory effects of energy-state changes	Suitable for combined experimental design with NAD+-related condition changes
S287227	Salermide	≥98% (HPLC)	Sirtuin-inhibition studies	Used for pharmacological inhibition of SIRT1/2 and evaluation of their effects on acetylation and metabolic phenotypes	Suitable for use as a contrast with SIRT1 activators
EJ1514230	Human Sirtuin 1 (SIRT1) ELISA Kit	BioReagent	SIRT1 level detection	Used to detect changes in SIRT1 level and assist in interpreting NAD+-dependent deacetylation capacity	Suitable for node quantification in human samples
Ab325941	Recombinant SIRT3 Antibody	Knockdown-validated	SIRT3 expression validation	Used to analyze mitochondrial SIRT3 expression and its role in local deacetylation	Suitable for studies of mitochondrial function and acetylation homeostasis
EJ1513919	Human Sirtuin3 (SIRT3) ELISA Kit	BioReagent	SIRT3 level detection	Used to detect SIRT3 levels and evaluate the state of mitochondrial deacetylation nodes	Suitable for studies of mitochondrial-protein acetylation
EJ1513767	Human Acetylated Histone H3 (AH3) ELISA Kit	BioReagent	Acetylation-phenotype readout	Used to detect histone H3 acetylation level as a terminal readout of acetyl-group writing and erasure effects	Suitable for validation of epigenetic changes after KAT, HDAC, and Sirtuin intervention

 

The key to research on acetyl-group metabolic enzymes lies in incorporating donor generation, compartmental distribution, modification writing, and modification removal into a unified analytical framework. Only when enzymatic behavior is interpreted within a continuous pathway context can the functional positioning of acetyl-group metabolism in pathway analysis and in vitro enzymology be accurately defined.